表紙
市場調查報告書

血液透析機、腹膜透析的全球市場 - 機會分析與產業預測:2020年∼2027年

Hemodialysis and Peritoneal Dialysis Market by Type, Dialysis Site, Modality, and Product : Global Opportunity Analysis and Industry Forecast, 2020-2027

出版商 Allied Market Research 商品編碼 955600
出版日期 內容資訊 英文 262 Pages
商品交期: 2-3個工作天內
價格
血液透析機、腹膜透析的全球市場 - 機會分析與產業預測:2020年∼2027年 Hemodialysis and Peritoneal Dialysis Market by Type, Dialysis Site, Modality, and Product : Global Opportunity Analysis and Industry Forecast, 2020-2027
出版日期: 2020年07月01日內容資訊: 英文 262 Pages
簡介

全球血液透析機、腹膜透析的市場規模,從2019年的156億8181萬美元,到2027年達到221億6486萬美元,在預測期間內預計以6.0%的年複合成長率成長。腎臟移植中包含大手術,捐贈者的選配,內臟器官的排斥反應的免疫抑製藥的終身制度,血液透析、腹膜透析市場成長,起因於腎臟相關疾病的發生率增加和腎臟移植相關的問題。

本報告提供全球血液透析機、腹膜透析市場相關調查分析,市場概要,市場規模與預測,各分類市場分析,各地區市場分析,競爭情形等相關的系統性資訊。

目錄

第1章 簡介

第2章 摘要整理

第3章 市場概要

  • 市場定義和範圍
  • 主要調查結果
  • 波特的五力分析
  • 主要企業的定位
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
  • HD、PD的得病率和發生率:重要的人口統計
  • 價格分析
  • 血管通路產品的平均生存期間
  • 透析的償付方案(每患者)
  • 血液透析機使用治療相關的主要罹患率的清單
  • 提供透析服務的主要企業的清單

第4章 血液透析機、腹膜透析市場:各類型

  • 血液透析機(HD)
  • 腹膜透析(PD)

第5章 血液透析機、腹膜透析市場:各透析網站

  • 概要
  • 醫院
  • 診所、透析中心
  • 家庭透析治療

第6章 血液透析機、腹膜透析市場:各種模式

  • 概要
  • 傳統
  • 每天(日中/夜間)

第7章 血液透析機、腹膜透析市場:各產品

  • 概要
  • 設備
  • 消耗品

第8章 血液透析機、腹膜透析市場:各地區

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 南美、中東、非洲

第9章 企業簡介

  • FRESENIUS SE AND CO. KGAA
  • ASAHI KASEI CORPORATION
  • B. BRAUN MELSUNGEN AG
  • BAXTER INTERNATIONAL INC.
  • BECTON, DICKINSON AND COMPANY (C. R. BARD, INC.)
  • COOK GROUP
  • ANGIODYNAMICS INC.
  • MEDTRONIC PLC.
  • NIKKISO CO. LTD.
  • NIPRO CORPORATION
目錄
Product Code: A03134

Title:
Hemodialysis and Peritoneal Dialysis Market by Type (Hemodialysis and Peritoneal Dialysis), Dialysis Site (Hospitals, Clinics & Dialysis Centers, and Home Dialysis), Modality (Conventional and Daily), and Product (Devices and Consumables): Global Opportunity Analysis and Industry Forecast, 2020-2027.

Dialysis is a technique used to remove waste products such as urea and creatinine from blood, which occurs from inappropriate functioning of kidneys. The procedure is vital during the treatment of end-stage renal disease (ESRD) and chronic kidney disease (CKD). Dialysis can be performed in two ways, namely; hemodialysis and peritoneal dialysis. In hemodialysis (HD), a filter is used to remove the waste products and extra fluids from blood. The purified blood is then reintroduced into the patient's body. On the other hand, peritoneal dialysis (PD) is a treatment that uses the inner lining of abdomen, called peritoneum and a dialysis solution to clean and purify blood and reinstate it into the patient's body. Both hemodialysis and peritoneal dialysis work on a similar principle of purifying the blood and removing toxins from patient's body, when kidneys are unable to function normally.

The global hemodialysis and peritoneal dialysis market was valued at $15,681.81 million in 2019, and is projected to reach $22,164.86 million by 2027, registering a CAGR of 6.0%. This market growth is attributed to surge in incidences of kidney related diseases and problems associated with kidney transplants as kidney transplantation involves a major surgery, a donor match, and a lifetime regime of immunosuppressant medications to prevent body refutation against the organ. In addition, rise in prevalence of lifestyle and chronic diseases such as obesity, diabetes, and hypertension are projected to further supplement the global hemodialysis and peritoneal dialysis market growth. Conversely, rise in complications related to dialysis treatment such as infections, hypotension, fluid overload, and access point bleeding are likely to obstruct growth of the market in the coming years.

Similarly, reimbursement policy concerns in emerging nations impedes growth of the market, as reimbursement for dialysis varies widely in terms of amount & duration between these countries and does not necessarily cover real treatment costs, further discouraging patients and physicians for considering the policy usage. On the other hand, shift in preference of patients toward home hemodialysis (HHD), owing to its effective and patient-centered approach and surge in market strategies such as acquisitions, partnerships, product development, and innovation by key players are expected to offer profitable opportunities for growth of the market during the forecast period.

The global hemodialysis and peritoneal dialysis market is segmented on the basis of type, dialysis site, modality, product, and region. By type, it is bifurcated into hemodialysis and peritoneal dialysis. The hemodialysis segment is further divided into short-term catheter, chronic catheter, graft, and fistula. By dialysis site, the market is classified into hospitals, clinics & dialysis centers, and home dialysis. By modality, it is categorized into conventional and daily (day time, night time). By product, it is segmented into devices and consumables. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

This report provides a detailed quantitative analysis of the current market trends and future estimations from 2020 to 2027, which assists to identify the prevailing market opportunities.

An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.

A comprehensive analysis of the factors that drive and restrain the growth of the hemodialysis and peritoneal dialysismarket is provided.

An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.

KEY MARKET SEGMENTS

By Type

  • Hemodialysis
  • Short-term Catheter
  • Chronic Catheter
  • Graft
  • Fistula
  • Peritoneal Dialysis

By Dialysis Site

  • Hospitals
  • Clinics &Dialysis Centers
  • Home Dialysis

By Modality

  • Conventional
  • Daily (Day Time, Night Time)

By Product

  • Devices
  • Consumables

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

KEY MARKET PLAYERS

  • Fresenius Medical Care AG & Co. KGaA
  • Baxter International Inc.
  • Nipro Corporation
  • B Braun Melsungen Ag
  • Nikkiso Co., Ltd.
  • Becton, Dickinson And Company (C. R. Bard, Inc.)
  • Cook Group
  • Angiodynamics Inc.
  • Medtronic PLC
  • Asahi Kasei Corp.

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key benefits to the stakeholders
  • 1.3.Key market segments
  • 1.4.Research methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools & models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
    • 3.2.2.Top winning strategies
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning, 2019
  • 3.5.Market dynamics
    • 3.5.1.Drivers
      • 3.5.1.1.Surge in incidences of kidney diseases
      • 3.5.1.2.Issues associated with kidney transplants
      • 3.5.1.3.Rise in prevalence of lifestyle and chronic diseases
    • 3.5.2.Restraints
      • 3.5.2.1.Complications in dialysis treatment
      • 3.5.2.2.Reimbursement policy concerns in emerging nations
    • 3.5.3.Opportunities
      • 3.5.3.1.Shift in preference of patients for home hemodialysis
      • 3.5.3.2.Surge in market strategies by key players
  • 3.6.Prevalence and Incidence of HD and PD: Important demographics
  • 3.7.Pricing analysis
  • 3.8.Average survival time of vascular access products
  • 3.9.Reimbursement scenario for dialysis (per patient)
  • 3.10.List of major morbidities associated with hemodialysis access procedures
  • 3.11.List of major companies delivering dialysis services

CHAPTER 4:HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE

  • 4.1.Overview
    • 4.1.1.Market size and forecast
  • 4.2.Hemodialysis (HD)
    • 4.2.1.Key market trends and opportunities
    • 4.2.2.Market size and forecast
    • 4.2.3.Market share analysis, by country
    • 4.2.4.Short-term Catheter (Non-cuffed tunneled catheters)
    • 4.2.5.Chronic Catheter (Cuffed tunneled catheters)
    • 4.2.6.Graft (AVG)
    • 4.2.7.Fistula (AVF)
  • 4.3.Peritoneal dialysis (PD)
    • 4.3.1.Key market trends and opportunities
    • 4.3.2.Market size and forecast
    • 4.3.3.Market share analysis, by country

CHAPTER 5:HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE

  • 5.1.Overview
    • 5.1.1.Market size and forecast
  • 5.2.Hospitals
    • 5.2.1.Key market trends and opportunities
    • 5.2.2.Market size and forecast, by region
    • 5.2.3.Market share analysis, by country
  • 5.3.Clinics & dialysis centers
    • 5.3.1.Key market trends and opportunities
    • 5.3.2.Market size and forecast, by region
    • 5.3.3.Market share analysis, by country
  • 5.4.Home dialysis
    • 5.4.1.Key market trends and opportunities
    • 5.4.2.Market size and forecast, by region
    • 5.4.3.Market share analysis, by country

CHAPTER 6:HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY

  • 6.1.Overview
    • 6.1.1.Market size and forecast
  • 6.2.Conventional dialysis
    • 6.2.1.Key market trends, growth factors, and opportunities
    • 6.2.2.Market size and forecast
    • 6.2.3.Market share analysis, by country
  • 6.3.Daily dialysis (Day time/ Night time)
    • 6.3.1.Key market trends, growth factors, and opportunities
    • 6.3.2.Market size and forecast
    • 6.3.3.Market share analysis, by country

CHAPTER 7:HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT

  • 7.1.Overview
    • 7.1.1.Market size and forecast
  • 7.2.Devices
    • 7.2.1.Key market trends, growth factors, and opportunities
    • 7.2.2.Market size and forecast
    • 7.2.3.Market share analysis, by country
  • 7.3.Consumables
    • 7.3.1.Key market trends, growth factors, and opportunities
    • 7.3.2.Market size and forecast
    • 7.3.3.Market share analysis, by country

CHAPTER 8:HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY REGION

  • 8.1.Overview
    • 8.1.1.Market size and forecast
  • 8.2.North America
    • 8.2.1.Key market trends and opportunities
    • 8.2.2.Market size and forecast, by country
    • 8.2.3.Market size and forecast, by type
    • 8.2.4.Market size and forecast, by dialysis site
    • 8.2.5.Market size and forecast, by modality
    • 8.2.6.Market size and forecast, by product
    • 8.2.7.U.S.
      • 8.2.7.1.Market size and forecast, by type
      • 8.2.7.2.Market size and forecast, by dialysis site
      • 8.2.7.3.Market size and forecast, by modality
      • 8.2.7.4.Market size and forecast, by product
    • 8.2.8.Canada
      • 8.2.8.1.Market size and forecast, by type
      • 8.2.8.2.Market size and forecast, by dialysis site
      • 8.2.8.3.Market size and forecast, by modality
      • 8.2.8.4.Market size and forecast, by product
    • 8.2.9.Mexico
      • 8.2.9.1.Market size and forecast, by type
      • 8.2.9.2.Market size and forecast, by dialysis site
      • 8.2.9.3.Market size and forecast, by modality
      • 8.2.9.4.Market size and forecast, by product
  • 8.3.Europe
    • 8.3.1.Key market trends and opportunities
    • 8.3.2.Market size and forecast, by country
    • 8.3.3.Market size and forecast, by type
    • 8.3.4.Market size and forecast, by dialysis site
    • 8.3.5.Market size and forecast, by modality
    • 8.3.6.Market size and forecast, by product
    • 8.3.7.UK
      • 8.3.7.1.Market size and forecast, by type
      • 8.3.7.2.Market size and forecast, by dialysis site
      • 8.3.7.3.Market size and forecast, by modality
      • 8.3.7.4.Market size and forecast, by product
    • 8.3.8.France
      • 8.3.8.1.Market size and forecast, by type
      • 8.3.8.2.Market size and forecast, by dialysis site
      • 8.3.8.3.Market size and forecast, by modality
      • 8.3.8.4.Market size and forecast, by product
    • 8.3.9.Spain
      • 8.3.9.1.Market size and forecast, by type
      • 8.3.9.2.Market size and forecast, by dialysis site
      • 8.3.9.3.Market size and forecast, by modality
      • 8.3.9.4.Market size and forecast, by product
    • 8.3.10.Italy
      • 8.3.10.1.Market size and forecast, by type
      • 8.3.10.2.Market size and forecast, by dialysis site
      • 8.3.10.3.Market size and forecast, by modality
      • 8.3.10.4.Market size and forecast, by product
    • 8.3.11.Germany
      • 8.3.11.1.Market size and forecast, by type
      • 8.3.11.2.Market size and forecast, by dialysis site
      • 8.3.11.3.Market size and forecast, by modality
      • 8.3.11.4.Market size and forecast, by product
    • 8.3.12.Rest of Europe
      • 8.3.12.1.Market size and forecast, by type
      • 8.3.12.2.Market size and forecast, by dialysis site
      • 8.3.12.3.Market size and forecast, by modality
      • 8.3.12.4.Market size and forecast, by product
  • 8.4.Asia-Pacific
    • 8.4.1.Key market trends and opportunities
    • 8.4.2.Market size and forecast, by country
    • 8.4.3.Market size and forecast, by type
    • 8.4.4.Market size and forecast, by dialysis site
    • 8.4.5.Market size and forecast, by modality
    • 8.4.6.Market size and forecast, by product
    • 8.4.7.Japan
      • 8.4.7.1.Market size and forecast, by type
      • 8.4.7.2.Market size and forecast, by dialysis site
      • 8.4.7.3.Market size and forecast, by modality
      • 8.4.7.4.Market size and forecast, by product
    • 8.4.8.China
      • 8.4.8.1.Market size and forecast, by type
      • 8.4.8.2.Market size and forecast, by dialysis site
      • 8.4.8.3.Market size and forecast, by modality
      • 8.4.8.4.Market size and forecast, by product
    • 8.4.9.Australia
      • 8.4.9.1.Market size and forecast, by type
      • 8.4.9.2.Market size and forecast, by dialysis site
      • 8.4.9.3.Market size and forecast, by modality
      • 8.4.9.4.Market size and forecast, by product
    • 8.4.10.India
      • 8.4.10.1.Market size and forecast, by type
      • 8.4.10.2.Market size and forecast, by dialysis site
      • 8.4.10.3.Market size and forecast, by modality
      • 8.4.10.4.Market size and forecast, by product
    • 8.4.11.South Korea
      • 8.4.11.1.Market size and forecast, by type
      • 8.4.11.2.Market size and forecast, by dialysis site
      • 8.4.11.3.Market size and forecast, by modality
      • 8.4.11.4.Market size and forecast, by product
    • 8.4.12.Rest of Asia-Pacific
      • 8.4.12.1.Market size and forecast, by type
      • 8.4.12.2.Market size and forecast, by dialysis site
      • 8.4.12.3.Market size and forecast, by modality
      • 8.4.12.4.Market size and forecast, by product
  • 8.5.LAMEA
    • 8.5.1.Key market trends and opportunities
    • 8.5.2.Market size and forecast, by country
    • 8.5.3.Market size and forecast, by type
    • 8.5.4.Market size and forecast, by dialysis site
    • 8.5.5.Market size and forecast, by modality
    • 8.5.6.Market size and forecast, by product
    • 8.5.7.Brazil
      • 8.5.7.1.Market size and forecast, by type
      • 8.5.7.2.Market size and forecast, by dialysis site
      • 8.5.7.3.Market size and forecast, by modality
      • 8.5.7.4.Market size and forecast, by product
    • 8.5.8.Saudi Arabia
      • 8.5.8.1.Market size and forecast, by type
      • 8.5.8.2.Market size and forecast, by dialysis site
      • 8.5.8.3.Market size and forecast, by modality
      • 8.5.8.4.Market size and forecast, by product
    • 8.5.9.South Africa
      • 8.5.9.1.Market size and forecast, by type
      • 8.5.9.2.Market size and forecast, by dialysis site
      • 8.5.9.3.Market size and forecast, by modality
      • 8.5.9.4.Market size and forecast, by product
    • 8.5.10.Rest of LAMEA
      • 8.5.10.1.Market size and forecast, by type
      • 8.5.10.2.Market size and forecast, by dialysis site
      • 8.5.10.3.Market size and forecast, by modality
      • 8.5.10.4.Market size and forecast, by product

CHAPTER 9:COMPANY PROFILES

  • 9.1.FRESENIUS SE AND CO. KGAA
    • 9.1.1.Company overview
    • 9.1.2.Company snapshot
    • 9.1.3.Operating business segments
    • 9.1.4.Product portfolio
    • 9.1.5.Business performance
    • 9.1.6.Key strategic moves and developments
  • 9.2.ASAHI KASEI CORPORATION
    • 9.2.1.Company overview
    • 9.2.2.Company snapshot
    • 9.2.3.Operating business segments
    • 9.2.4.Product portfolio
    • 9.2.5.Business performance
  • 9.3.B. BRAUN MELSUNGEN AG
    • 9.3.1.Company overview
    • 9.3.2.Company snapshot
    • 9.3.3.Operating business segments
    • 9.3.4.Product portfolio
    • 9.3.5.Business performance
    • 9.3.6.Key strategic moves and developments
  • 9.4.BAXTER INTERNATIONAL INC.
    • 9.4.1.Company overview
    • 9.4.2.Company snapshot
    • 9.4.3.Operating business segments
    • 9.4.4.Product portfolio
    • 9.4.5.Business performance
    • 9.4.6.Key strategic moves and developments
  • 9.5.BECTON, DICKINSON AND COMPANY (C. R. BARD, INC.)
    • 9.5.1.Company overview
    • 9.5.2.Company snapshot
    • 9.5.3.Operating business segments
    • 9.5.4.Product portfolio
    • 9.5.5.Business performance
    • 9.5.6.Key strategic moves and developments
  • 9.6.COOK GROUP
    • 9.6.1.Company overview
    • 9.6.2.Company snapshot
    • 9.6.3.Operating business segments
    • 9.6.4.Product portfolio
  • 9.7.ANGIODYNAMICS INC.
    • 9.7.1.Company overview
    • 9.7.2.Company snapshot
    • 9.7.3.Operating business segments
    • 9.7.4.Product portfolio
    • 9.7.5.Business performance
  • 9.8.MEDTRONIC PLC.
    • 9.8.1.Company overview
    • 9.8.2.Company snapshot
    • 9.8.3.Operating business segments
    • 9.8.4.Product portfolio
    • 9.8.5.Business performance
    • 9.8.6.Key strategic moves and developments
  • 9.9.NIKKISO CO. LTD.
    • 9.9.1.Company overview
    • 9.9.2.Company snapshot
    • 9.9.3.Operating business segments
    • 9.9.4.Product portfolio
    • 9.9.5.Business performance
  • 9.10.NIPRO CORPORATION
    • 9.10.1.Company overview
    • 9.10.2.Company snapshot
    • 9.10.3.Operating business segments
    • 9.10.4.Product portfolio
    • 9.10.5.Business performance

LIST OF TABLES

  • TABLE 01.SIDE EFFECTS OF DIALYSIS
  • TABLE 02.PREVALENCE AND INCIDENCE OF HEMODIALYSIS AND PERITONEAL DIALYSIS PATIENT (NUMBER OF PATIENTS IN THOUSANDS)
  • TABLE 03.PRICING ANALYSIS BY ACCESS TYPE: AVERAGE PRICING RANGE (USD)
  • TABLE 04.AVERAGE SURVIVAL TIME OF VASCULAR ACCESS PRODUCTS
  • TABLE 05.ACCESS FISTULA AND GRAFTS
  • TABLE 06.ACCESS CATHETERS
  • TABLE 07.LIST OF MAJOR COMPANIES DELIVERING DIALYSIS SERVICES
  • TABLE 08.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 09.GLOBAL HEMODIALYSIS PATIENTS, BY ACCESS TYPE (NUMBER OF PATIENTS IN THOUSANDS)
  • TABLE 10.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SEGMENT, BY REGION, 2019-2027 ($MILLION)
  • TABLE 11.GLOBAL HEMODIALYSIS PATIENTS WITH SHORT TERM CATHETER ACCESS, BY REGION (NUMBER OF PATIENTS IN THOUSANDS)
  • TABLE 12.GLOBAL HEMODIALYSIS PATIENTS WITH CHRONIC CATHETER ACCESS, BY REGION (NUMBER OF PATIENTS IN THOUSANDS)
  • TABLE 13.GLOBAL HEMODIALYSIS PATIENTS WITH GRAFT ACCESS, BY REGION (NUMBER OF PATIENTS IN THOUSANDS)
  • TABLE 14.GLOBAL HEMODIALYSIS FISTULA MARKET, BY REGION (NUMBER OF PATIENTS IN THOUSANDS)
  • TABLE 15.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS SEGMENT, BY REGION, 2019-2027 ($MILLION)
  • TABLE 16.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 17.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HOSPITALS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 18.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR CLINICS AND DIALYSIS CENTERS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 19.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HOME DIALYSIS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 20.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019-2027 ($MILLION)
  • TABLE 21.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR CONVENTIONAL DIALYSIS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 22.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR DAILY DIALYSIS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 23.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 24.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR DEVICES, BY REGION, 2019-2027 ($MILLION)
  • TABLE 25.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR CONSUMABLES, BY REGION, 2019-2027 ($MILLION)
  • TABLE 26.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 27.NORTH AMERICA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 28.NORTH AMERICA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 29.NORTH AMERICA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 30.NORTH AMERICA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019-2027 ($MILLION)
  • TABLE 31.NORTH AMERICA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 32.U.S. HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 33.U.S. HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 34.U.S. HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 35.U.S. HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 36.CANADA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 37.CANADA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 38.CANADA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 39.CANADA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 40.MEXICO HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 41.MEXICO HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 42.MEXICO HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019-2027 ($MILLION)
  • TABLE 43.MEXICO HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 44.EUROPE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 45.EUROPE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 46.EUROPE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 47.EUROPE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019-2027 ($MILLION)
  • TABLE 48.EUROPE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 49.UK HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 50.UK HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 51.UK HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019-2027 ($MILLION)
  • TABLE 52.UK HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 53.FRANCE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 54.FRANCE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 55.FRANCE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019-2027 ($MILLION)
  • TABLE 56.FRANCE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 57.SPAIN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 58.SPAIN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 59.SPAIN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019-2027 ($MILLION)
  • TABLE 60.SPAIN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 61.ITALY HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 62.ITALY HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 63.ITALY HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019-2027 ($MILLION)
  • TABLE 64.ITALY HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 65.GERMANY HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 66.GERMANY HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 67.GERMANY HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019-2027 ($MILLION)
  • TABLE 68.GERMANY HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 69.REST OF EUROPE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 70.REST OF EUROPE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 71.REST OF EUROPE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019-2027 ($MILLION)
  • TABLE 72.REST OF EUROPE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 73.ASIA-PACIFIC HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 74.ASIA-PACIFIC HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 75.ASIA-PACIFIC HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 76.ASIA-PACIFIC HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019-2027 ($MILLION)
  • TABLE 77.ASIA-PACIFIC HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 78.JAPAN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 79.JAPAN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 80.JAPAN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019-2027 ($MILLION)
  • TABLE 81.JAPAN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 82.CHINA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 83.CHINA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 84.CHINA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019-2027 ($MILLION)
  • TABLE 85.CHINA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 86.AUSTRALIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 87.AUSTRALIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 88.AUSTRALIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019-2027 ($MILLION)
  • TABLE 89.AUSTRALIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 90.INDIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 91.INDIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 92.INDIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019-2027 ($MILLION)
  • TABLE 93.INDIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 94.SOUTH KOREA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 95.SOUTH KOREA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 96.SOUTH KOREA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019-2027 ($MILLION)
  • TABLE 97.SOUTH KOREA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 98.REST OF ASIA-PACIFIC HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 99.REST OF ASIA-PACIFIC HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 100.REST OF ASIA-PACIFIC HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019-2027 ($MILLION)
  • TABLE 101.REST OF ASIA-PACIFIC HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 102.LAMEA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 103.LAMEA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 104.LAMEA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 105.LAMEA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019-2027 ($MILLION)
  • TABLE 106.LAMEA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 107.BRAZIL HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 108.BRAZIL HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 109.BRAZIL HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019-2027 ($MILLION)
  • TABLE 110.BRAZIL HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 111.SAUDI ARABIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 112.SAUDI ARABIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 113.SAUDI ARABIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019-2027 ($MILLION)
  • TABLE 114.SAUDI ARABIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 115.SOUTH AFRICA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 116.SOUTH AFRICA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 117.SOUTH AFRICA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019-2027 ($MILLION)
  • TABLE 118.SOUTH AFRICA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 119.REST OF LAMEA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 120.REST OF LAMEA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019-2027 ($MILLION)
  • TABLE 121.REST OF LAMEA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019-2027 ($MILLION)
  • TABLE 122.REST OF LAMEA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 123.FRESENIUS: COMPANY SNAPSHOT
  • TABLE 124.FRESENIUS: OPERATING SEGMENTS
  • TABLE 125.FRESENIUS: PRODUCT PORTFOLIO
  • TABLE 126.FRESENIUS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 127.ASAHI KASEI: COMPANY SNAPSHOT
  • TABLE 128.ASAHI KASEI: OPERATING SEGMENTS
  • TABLE 129.ASAHI KASEI: PRODUCT PORTFOLIO
  • TABLE 130.B. BRAUN: COMPANY SNAPSHOT
  • TABLE 131.B. BRAUN: OPERATING SEGMENTS
  • TABLE 132.B. BRAUN: PRODUCT PORTFOLIO
  • TABLE 133.B. BRAUN: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 134.BAXTER: COMPANY SNAPSHOT
  • TABLE 135.BAXTER: OPERATING SEGMENTS
  • TABLE 136.BAXTER: PRODUCT PORTFOLIO
  • TABLE 137.BAXTER: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 138.BD: COMPANY SNAPSHOT
  • TABLE 139.BD: OPERATING SEGMENTS
  • TABLE 140.BD: PRODUCT PORTFOLIO
  • TABLE 141.BD: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 142.COOK: COMPANY SNAPSHOT
  • TABLE 143.COOK: OPERATING SEGMENTS
  • TABLE 144.COOK: PRODUCT PORTFOLIO
  • TABLE 145.ANGIODYNAMICS: COMPANY SNAPSHOT
  • TABLE 146.ANGIODYNAMICS: PRODUCT SEGMENTS
  • TABLE 147.ANGIODYNAMICS: PRODUCT PORTFOLIO
  • TABLE 148.MEDTRONIC: COMPANY SNAPSHOT
  • TABLE 149.MEDTRONIC: OPERATING SEGMENTS
  • TABLE 150.MEDTRONIC: PRODUCT PORTFOLIO
  • TABLE 151.MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 152.NIKKISO: COMPANY SNAPSHOT
  • TABLE 153.NIKKISO: OPERATING SEGMENTS
  • TABLE 154.NIKKISO: PRODUCT PORTFOLIO
  • TABLE 155.NIPRO: COMPANY SNAPSHOT
  • TABLE 156.NIPRO: OPERATING SEGMENTS
  • TABLE 157.NIPRO: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01.SEGMENTATION OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET
  • FIGURE 02.TOP INVESTMENT POCKETS IN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET
  • FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2016-2019*
  • FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2016-2019* (%)
  • FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2016-2019*
  • FIGURE 06.HIGH BARGAINING POWER OF BUYERS
  • FIGURE 07.MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 08.MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 09.MODERATE THREAT OF SUBSTITUTION
  • FIGURE 10.HIGH COMPETITIVE RIVALRY
  • FIGURE 11.TOP PLAYER POSITIONING, 2019
  • FIGURE 12.RESTRAINTS AND DRIVERS: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET
  • FIGURE 13.PROJECTED PREVALENCE OF CKD IN 2020 AND 2030 IN ADULTS AGED 30 YEARS OR OLDER (U.S.)
  • FIGURE 14.PREVALENCE OF DIABETES IN POPULATION (MILLIONS) AND DIABETES PREVALENCE (%)
  • FIGURE 15.DIALYSIS REIMBURSEMENT SCENARIO AROUND THE WORLD
  • FIGURE 16.COMPARATIVE ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SEGMENT, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 17.COMPARATIVE ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS SEGMENT, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 18.COMPARATIVE ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HOSPITALS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 19.COMPARATIVE ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR CLINICS AND DIALYSIS CENTERS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 20.COMPARATIVE ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HOME DIALYSIS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 21.COMPARATIVE ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR CONVENTIONAL DIALYSIS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 22.COMPARATIVE ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR DAILY DIALYSIS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 23.COMPARATIVE ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR DEVICES, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 24.COMPARATIVE ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 25.GLOBAL PREVALENCE OF DIALYSIS, RATE PER MILLION POPULATION (PMP), AGE ≥ 18 YEARS
  • FIGURE 26.TRENDS IN ANNUAL NUMBER OF ESRD INCIDENT CASES AND STANDARD INCIDENCES RATES PER MILLION EACH YEAR, U.S.
  • FIGURE 27.FRESENIUS: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 28.FRESENIUS: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 29.FRESENIUS: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 30.ASAHI KASEI: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 31.ASAHI KASEI: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 32.ASAHI KASEI: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 33.B. BRAUN: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 34.B. BRAUN: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 35.B. BRAUN: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 36.BAXTER: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 37.BAXTER: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 38.BAXTER: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 39.BD: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 40.BD: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 41.BD: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 42.ANGIODYNAMICS: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 43.ANGIODYNAMICS: REVENUE SHARE, BY SEGMENTS, 2019 (%)
  • FIGURE 44.ANGIODYNAMICS: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 45.MEDTRONIC: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 46.MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 47.MEDTRONIC: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 48.NIKKISO: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 49.NIKKISO: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 50.NIKKISO: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 51.NIPRO: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 52.NIPRO: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 53.NIPRO: REVENUE SHARE, BY REGION, 2019 (%)